Voyager Therapeutics Announces Second Quarter 2023 Conference Call and Webcast
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR) a biotechnology company dedicated to breaking through...
Month: July 2023
Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference
ALACHUA and TAMPA, Fla., July 27, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and...
Tilray Renews Distribution Agreement With Great North Distributors for Cannabis Sales Across Canada With Newly Expanded Brand Portfolio
Tilray Continues to Lead Cannabis Market Share Across CanadaLEAMINGTON, Ontario, July 27, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq:...
Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference
CARLSBAD, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on...
Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
DURHAM, N.C., July 27, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully...
NeuroMetrix Reports Q2 2023 Business Highlights
WOBURN, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the...
Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2023
BANNOCKBURN, Ill., July 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH),...
Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million
Second Quarter 2023 Conference Call and Webcast to be held August 10, 2023 at 8:00 a.m. Eastern Time Company plans...
Aquestive Therapeutics Announces Positive Topline Pharmacokinetic Data for Anaphylm™ (epinephrine) Sublingual Film
Anaphylm 12mg Exceeds Lower Bracket at All Expected Pivotal Targets Anaphylm 12mg Exceeds Lower Bracket at All Expected Pivotal TargetsReports...
EyePoint Pharmaceuticals Presents Interim Masked Safety Data and Patient Baseline Characteristics for DAVIO 2 Clinical Trial at OIS Retina Innovation Summit
Interim safety data from the Phase 2 DAVIO 2 trial continues to demonstrate EYP-1901 is well tolerated with no reported...
Plus Therapeutics to Present at the 2023 SNO/ASCO CNS Cancer Conference
AUSTIN, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted...
Kymera Therapeutics to Report Second Quarter 2023 Financial Results on August 3
WATERTOWN, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein...
Fulcrum Therapeutics to Host Second Quarter 2023 Financial Results Conference Call and Webcast on Thursday, August 3, 2023, at 8:00 a.m. ET
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused...
Annexon Biosciences Strengthens Leadership Team with Appointment of Jamie Dananberg, M.D., as Chief Medical Officer
BRISBANE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new...
IBA Notice of Half Year 2023 Results and Conference Call
HY23 results meeting to take place as a hybrid event on Thursday, 31 August 2023 at 3 pm CEST Louvain-la-Neuve,...
Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023
IRVINE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN)(“Sientra” or the “Company”), a medical aesthetics company developing...
Neural Therapeutics Receives Key Permission from Peruvian Government to Harvest and Work with the San Pedro Cactus Containing Mescaline
Permission enables company to conduct research with potentially patentable outcomesRare permission granted due to Company's commitment to knowledge transfer and...
Brüush Oral Care Inc. Announces Receipt of Notice from Nasdaq Regarding the Determination of Delisting
VANCOUVER, BC / ACCESSWIRE / July 26, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it...
DEA Defies President Biden’s Marijuana Research Act – MMJ Sends DEA Warning Letter
Congress Gets Warning Letter: "Be Aware The DEA Is Breaking The Law",MMJ ATTORNEY Megan Sheehan SaysZINGER KEY POINTSDEA inaction is...
AWS Announces AWS HealthScribe, a New Generative AI-Powered Service that Automatically Creates Clinical Documentation
New service leverages speech recognition and generative AI to automatically create preliminary clinical documentation from patient-clinician conversations 3M Health Information...